D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Code

D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
[Billable]

Includes

  • Antithromboplastinemia
  • Antithromboplastinogenemia
  • Hemorrhagic disorder due to intrinsic increase in antithrombin
  • Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
  • Hemorrhagic disorder due to intrinsic increase in anti-IXa
  • Hemorrhagic disorder due to intrinsic increase in anti-XIa

Code Tree

D50-D89 - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
  • D65-D69 - Coagulation defects, purpura and other hemorrhagic conditions
    • D68 - Other coagulation defects
      • D68.3 - Hemorrhagic disorder due to circulating anticoagulants
        • D68.31 - Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
          • D68.311 - Acquired hemophilia
          • D68.312 - Antiphospholipid antibody with hemorrhagic disorder
          • D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Map to ⑨

D68.318 converts to ICD-9-CM:
  • 286.59 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors is a sample topic from the ICD-10-CM.

To view other topics, please or .

ICD-10-CM 2020 Coding Guide™ from Unbound Medicine. Search online 72,000+ ICD-10 codes by number, disease, injury, drug, or keyword. .